Escin IB T5S1389
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Escin Ib inhibits gastric emptying, at least in part, mediated by capsaicin-sensitive sensory nerves, to stimulate the synthesis and/or release of dopamine, to act through central dopamine2 receptor, which in turn causes the release of PGs.
CAS nr:
26339-90-2
Purity:
98%
Molecular Weight:
1131,3
SMILES:
[H][C@@]12CC(C)(C)[C@@H](OC(=O)C(\C)=C/C)[C@H](OC(C)=O)[C@]1(CO)[C@H](O)C[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O[C@@H]4O[C@@H]([C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(O)=O)[C@](C)(CO)[C@]3([H])CC[C@@]12C
Formula:
C55H86O24
Pathway:
Neuroscience,GPCR/G Protein,Immunology/Inflammation
Target:
5-HT Receptor,5-HT Receptor,NO Synthase
